A critical advance in cancer study is emerging with the use of VHH fragments to restore dysfunctional p53. This essential malignant inhibitor protein is frequently inactivated in many types of cancer, leading https://pr7bookmark.com/story22224038/vhh-fragments-reactivate-p53-new-new-approach-for-malignant-therapy